After an infection, experts give advice on how to use eye creams correctly.

Published Date: 08 Mar 2023

Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.

Read Full News

Latest News

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

A glaucoma diagnosis at a young age should prompt timely genetic testing

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

News All Time

Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

ARVO Video Pearls: Video Pearls From The Association for Research in Vision and Ophthalmology

ASRS: American Society of Retina Specialists

AAO: American Academy of Ophthalmology

Trump Showing His Age? Nasal Spray Recalled; Elton John on Losing Sight

Health news and commentary gathered by MedPage Today staff

ARVO: Association for Research in Vision and Ophthalmology

AAO Video Pearls: Video Pearls from the American Academy of Ophthalmology

Pay Cuts and Unnecessary Visits: How Medicare Is Compromising Cataract Care

It's time for payment reform and a lasting remote follow-up option

Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

Patients with PCV gain standard-dose benefits, with less-frequent dosing

Recommended News For You

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

Abemaciclib Slows Progression of Advanced Liposarcoma

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

Prostate cancer early detection system eliminates need for biopsy.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Recommended Articles For You

Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025 

Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer 

The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease  

Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Routine breast cancer screening can bring better outcomes for patients

2.

Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment

3.

FDA approves rivanetin as the first-line treatment for lung cancer.

4.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

5.

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

1.

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential

2.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

3.

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

5.

Clinical Perspectives in Oncology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

2.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

3.

A New Era in Managing Cancer-Associated Thrombosis

4.

Navigating the Complexities of Ph Negative ALL - Part XII

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot